Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (FY)Jan 31, 2023 | (FY)Jan 31, 2022 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 82.22M | 79.27M | 73.76M | 73.63%207.71M | 60.03M | 280.17%119.63M | 31.47M |
| Cost of revenue | 57.46M | 59.26M | 54.75M | 66.52%144.34M | 41.69M | 139.74%86.68M | 36.15M |
| Gross profit | 24.76M | 20.01M | 19.02M | 92.30%63.38M | 18.34M | 803.24%32.96M | -4.69M |
| Operating expense | 6.08M | 6.17M | 5.47M | 71.63%14.86M | 4.94M | 16.98%8.66M | 7.4M |
| Staff costs | ---- | ---- | ---- | 36.44%7.56M | --2.42M | 20.80%5.54M | --4.59M |
| Selling and administrative expenses | --6.08M | --6.17M | --5.47M | 103.87%6.59M | --2.22M | 111.24%3.23M | --1.53M |
| -Selling and marketing expense | --173K | --668K | --795K | 112.88%2.64M | --959K | 145.45%1.24M | --506K |
| -General and administrative expense | --5.91M | --5.51M | --4.67M | 98.24%3.95M | --1.26M | 94.34%1.99M | --1.02M |
| Depreciation and amortization | ---- | ---- | ---- | 24.42%1.23M | --306K | -38.89%987K | --1.62M |
| -Depreciation | ---- | ---- | ---- | 24.42%1.23M | --306K | -38.89%987K | --1.62M |
| Other operating expenses | ---- | ---- | ---- | 489.39%1.06M | --294K | 184.13%179K | --63K |
| Total other operating income | ---- | ---- | ---- | 22.82%1.58M | --299K | 224.24%1.28M | --396K |
| Operating profit | 18.68M | 13.84M | 13.55M | 99.66%48.52M | 13.4M | 301.08%24.3M | -12.09M |
| Net non-operating interest income (expenses) | -2.37M | -2.27M | -2.14M | -56.69%-4.73M | -1.15M | -80.51%-3.02M | -1.67M |
| Non-operating interest expense | --2.37M | --2.27M | --2.14M | 56.69%4.73M | --1.15M | 80.51%3.02M | --1.67M |
| Net investment income | 1.59M | 263K | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||
| Income from associates and other participating interests | |||||||
| Special income (charges) | -144.08%-2.11M | -1.82M | 96.25%-864K | -23.07M | |||
| Less:Impairment of capital assets | ---- | ---- | ---- | 64.29%1.47M | --1.14M | -35.68%896K | --1.39M |
| Less:Write off | ---- | ---- | ---- | 2,090.17%636.85K | --686.85K | -100.15%-32K | --21.67M |
| Other non-operating income (expenses) | 1.5M | 4.96M | 3.73M | -1.47%1.88M | 454K | -6.29%1.91M | 2.04M |
| Income before tax | 17.81M | 16.53M | 15.14M | 102.22%45.15M | 11.14M | 164.17%22.32M | -34.79M |
| Income tax | 3.04M | 2.66M | 2.53M | 325.97%11.97M | 2.18M | 202.40%2.81M | -2.75M |
| Net income | 14.77M | 13.88M | 12.6M | 69.99%33.17M | 8.97M | 160.89%19.51M | -32.05M |
| Net income continuous operations | --14.77M | --13.88M | --12.6M | 69.99%33.17M | --8.97M | 160.89%19.51M | ---32.05M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | 14.77M | 13.88M | 12.6M | 69.99%33.17M | 8.97M | 160.89%19.51M | -32.05M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 14.77M | 13.88M | 12.6M | 69.99%33.17M | 8.97M | 160.89%19.51M | -32.05M |
| Gross dividend payment | |||||||
| Basic earnings per share | 0.0315 | 0.0306 | 0.0311 | 69.99%0.0663 | 0.0179 | 160.89%0.039 | -0.0641 |
| Diluted earnings per share | 0.0315 | 0.0306 | 0.0311 | 69.99%0.0663 | 0.0179 | 160.89%0.039 | -0.0641 |
| Dividend per share | 0.01 | 0.01 | |||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.